CSANZ Logo
CSANZ Logo
Welcome to the official website of the


CSANZ Logo
CSANZ Logo
Cardiac Society of Australia and New Zealand
CSANZ Logo


CSANZ Logo


CSANZ Logo

contact
links
want to join?
register
search the CSANZ website
search the CSANZ website
     







search the CSANZ website













CSANZ Directory

CSANZ Member Directory

CSANZ Guidelines

Practice Guidelines

Training and Competence

Meetings

What's On and Where

ASM Abstracts Online

News and Views

Newsletter - On the Pulse

Newsletter - CNWG

In the News

Affiliate News
Career Opportunities

Affiliate Member Area

Affiliate Calendar

Affiliate Discussion

Scholarships/ Fellowships

Working Groups


ASM Abstracts

TWENTY-EIGHT YEARS FOLLOW-UP OF PRIMARY AORTIC VALVE REPLACEMENT WITH ALLOGRAFTS -AN ECHOCARDIOGRAPHIC STUDY OF 613 PATIENTS.

P. Palka*, S. Harrocks, A. Lange, M. Davison, D. Burstow, M. O'Brien.

Departments of Echocardiography and Cardiac Surgery, The Prince Charles Hospital, Brisbane, Qld.

Since the 1960s when aortic allografts (AA) have been introduced, it has been apparent that this kind of aortic valve surgery offers many advantages over the prosthetic valves.  The main concern regarding the AA is its durability.  Aim of this study was to assess the contributing factors for long time uneventful longevity of AA and to define potential failure factors in this group of patients during the 28-year follow-up.  AA implantation was performed by a subcoronary technique or a total root replacement in a group of 1022 pts (mean age 48±17 years, 669 male).  The AA were cryopreserved (n=898) or nonviable (n=124).

Results:  30-day mortality for the entire group was 3.0% (the last consecutive 352 pts all having root replacement was 1.1%).  Crude survival was 65% at >25 years follow-up.  The re-operation rate was 11.2% (n=135) at a mean time post surgery of 9.4 ± 5.8 years.  To assess the performance of AA, echocardiographic studies were performed between 1996-1998 in 613 patients (between 89 days to 25 years post AA implantation, mean 6.7 years).  During that period, in 487 (79%) patients there were no echocardiographic signs of either AA stenosis (AAS) or regurgitation (AAR).  42 patients (7%) had AAS and 81 (13%) AAR.  There was no differences between AAS, AAR and normal AA in several valve-and procedure-related determinants (see Table).  However, AA patients who died or had aortic valve re-operation had larger aortic annulus size (recipients to donor difference) as compared to patients with normal AA derived by echocardiogram (3.4±2.2cm vs 2.3±2.2cm, P<0.001).

AAS
(n=42)

AAR
(n=81)

Normal AA (n=490)

Non‑- viable Aortic Valve

0

3 (4%)

6 (1%)

Cryopreserved Aortic Valve

42 (100%)

78 (96%)

484 (99%)

Procurement time (hrs)

14.3±8.1

14.8±7.5

15.2±8.5

Patients age (yrs)

41±19

50±16

47±16

Age recipient/donor Difference (yrs)

14±23

20±23

15±21

Aortic annulus Recipients/donor difference (cm)

2.3±1.6

2.7±2.5

2.3±2.3

Conclusions:  AA replacement gives good long term results at follow-up of up to 28 years.  There was a trend for AAR patients and those who died or needed re-operation to be older and have bigger annulus diameter.  No other specific patient

[ Back to 48th ASM Abstract Index ]


Med-E-Serv